


The Native Antigen Company (Part of LGC Clinical Diagnostics) has moved to a new state-of-the-art site in Oxford, delivering critical diagnostics solutions and research.
Left to Right: Euan O’Sullivan (President and Chief Executive Officer LGC Group), Dame Sarah Gilbert DBE , Mark Dearden (Managing Director, LGC Biosearch Technologies) Teresa Lambe OBE, Nicholas Roesen, (COO The Native Antigen Company), Bharathi Anekella...